Associations Between Endothelial Progenitor Cells, Clinical Characteristics and Coronary Restenosis in Patients Undergoing Percutaneous Coronary Artery Intervention

Overview

Journal BMC Res Notes

Publisher Biomed Central

Specialties Biology
General Medicine

Date 2018 May 10

PMID 29739448

Citations 7

Authors

Fernando S Montenegro

Marcelo Correia

Fabiana Muccillo

Christina G Souza E Silva

Andrea De Lorenzo

Affiliations

Soon will be listed here.

Abstract

Objective: Endothelial progenitor cells (EPCs) are produced in the bone marrow and mobilized to the peripheral blood playing a key role in endothelial repair. The objective of this study was to evaluate circulating EPC before and after percutaneous coronary intervention (PCI) with stent implantation and their associations with coronary restenosis and adverse cardiovascular events. Venous blood was obtained before and the day after PCI. Quantification of total white blood count and identification of EPCs (CD45CD34CD31CD133/2CD309) through immunophenotyping by flow cytometry was performed. The primary outcome was either restenosis detected by new coronary angiography or angina with myocardial ischemia at the territory of the stented coronary artery. Secondary outcomes were angina without demonstrable myocardial ischemia, acute coronary syndrome or all-cause death.

Results: 37 patients were followed for 1 year. The median EPC count before PCI was 320 cells/mcl and after PCI 286 cells/mcl. A decrease of EPC count was found in 65% of the patients, while 35% displayed an increase. Primary outcomes occurred in 10.8% and the secondary in 37.8% of the patients. Despite a higher level of EPC before (402 cell/mcl) and after PCI (383 cell/mcl) in patients with the secondary outcomes, there was no significant association between EPC and cardiovascular events.

Citing Articles

Microarray meta-analysis reveals IL6 and p38β/MAPK11 as potential targets of hsa-miR-124 in endothelial progenitor cells: Implications for stent re-endothelization in diabetic patients.

Arencibia A, Salazar L Front Cardiovasc Med. 2022; 9:964721.

PMID: 36176980 PMC: 9513120. DOI: 10.3389/fcvm.2022.964721.

Restenosis after Coronary Stent Implantation: Cellular Mechanisms and Potential of Endothelial Progenitor Cells (A Short Guide for the Interventional Cardiologist).

Gori T Cells. 2022; 11(13).

PMID: 35805178 PMC: 9265311. DOI: 10.3390/cells11132094.

Endothelial Progenitor Cells in Coronary Artery Disease: From Bench to Bedside.

Pelliccia F, Zimarino M, De Luca G, Viceconte N, Tanzilli G, De Caterina R Stem Cells Transl Med. 2022; 11(5):451-460.

PMID: 35365823 PMC: 9154346. DOI: 10.1093/stcltm/szac010.

Effects of Shen-Yuan-Dan on Periprocedural Myocardial Injury and the Number of Peripheral Blood Endothelial Progenitor Cells in Patients with Unstable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention.

Zhang Z, Xing W, Liu H, Zhou Q, Liu X, Shang J Evid Based Complement Alternat Med. 2022; 2022:9055585.

PMID: 35035512 PMC: 8759927. DOI: 10.1155/2022/9055585.

Polysaccharide Prevents Restenosis of Vein Graft Through Inhibiting Cell Proliferation in Rat Model.

Dai C, Zhou Y, Zhang B, Ge J Cell Transplant. 2020; 29:963689720969173.

PMID: 33267619 PMC: 7873761. DOI: 10.1177/0963689720969173.

References

Leopold J . Prohealing endothelial progenitor cell capture stents: do the cells captured explain the clinical outcomes?. Circ Cardiovasc Interv. 2013; 6(5):494-5. PMC: 3891605. DOI: 10.1161/CIRCINTERVENTIONS.113.000812. View

Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan E . Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med. 2015; 372(13):1213-22. DOI: 10.1056/NEJMoa1412168. View

Padfield G, Newby D, Mills N . Understanding the role of endothelial progenitor cells in percutaneous coronary intervention. J Am Coll Cardiol. 2010; 55(15):1553-65. DOI: 10.1016/j.jacc.2009.10.070. View

Banerjee S, Brilakis E, Zhang S, Roesle M, Lindsey J, Philips B . Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis. 2006; 189(1):70-5. DOI: 10.1016/j.atherosclerosis.2006.04.026. View

Leor J, Marber M . Endothelial progenitors: a new Tower of Babel?. J Am Coll Cardiol. 2006; 48(8):1588-90. DOI: 10.1016/j.jacc.2006.07.032. View

Masuda H, Kalka C, Takahashi T, Yoshida M, Wada M, Kobori M . Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res. 2007; 101(6):598-606. DOI: 10.1161/CIRCRESAHA.106.144006. View

Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon M, Kutryk M . Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol. 2004; 44(4):733-9. DOI: 10.1016/j.jacc.2004.04.048. View

Grant M, May W, Caballero S, Brown G, Guthrie S, Mames R . Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 2002; 8(6):607-12. DOI: 10.1038/nm0602-607. View

Fischman D, Leon M, Baim D, Schatz R, Savage M, Penn I . A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994; 331(8):496-501. DOI: 10.1056/NEJM199408253310802. View

10.

Yao E, Fukuda N, Matsumoto T, Katakawa M, Yamamoto C, Han Y . Effects of the antioxidative beta-blocker celiprolol on endothelial progenitor cells in hypertensive rats. Am J Hypertens. 2008; 21(9):1062-8. DOI: 10.1038/ajh.2008.233. View

11.

Park S, Kang S, Virmani R, Nakano M, Ueda Y . In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol. 2012; 59(23):2051-7. DOI: 10.1016/j.jacc.2011.10.909. View

12.

Dangas G, Claessen B, Caixeta A, Sanidas E, Mintz G, Mehran R . In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010; 56(23):1897-907. DOI: 10.1016/j.jacc.2010.07.028. View

13.

Welt F, Rogers C . Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002; 22(11):1769-76. DOI: 10.1161/01.atv.0000037100.44766.5b. View

14.

Arjomand H, Turi Z, McCormick D, Goldberg S . Percutaneous coronary intervention: historical perspectives, current status, and future directions. Am Heart J. 2003; 146(5):787-96. DOI: 10.1016/S0002-8703(03)00153-4. View

15.

Antonio N, Fernandes R, Rodriguez-Losada N, Jimenez-Navarro M, Paiva A, de Teresa Galvan E . Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs. Eur J Clin Pharmacol. 2009; 66(3):219-30. DOI: 10.1007/s00228-009-0764-y. View

16.

Misumida N, Aoi S, Saeed M, Ota T, Eda T, Umeda H . The role of angiographic follow-up after percutaneous coronary intervention. Int J Cardiol. 2016; 222:911-920. DOI: 10.1016/j.ijcard.2016.08.031. View

17.

Pelliccia F, Cianfrocca C, Rosano G, Mercuro G, Speciale G, Pasceri V . Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study. JACC Cardiovasc Interv. 2010; 3(1):78-86. DOI: 10.1016/j.jcin.2009.10.020. View

18.

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

19.

Lee L, Chen C, Choong P, Low A, Tan H, Poh K . Time-dependent dynamic mobilization of circulating progenitor cells during percutaneous coronary intervention in diabetics. Int J Cardiol. 2009; 142(2):199-201. DOI: 10.1016/j.ijcard.2008.11.198. View

20.

Gao M, Yao Q, Liu Y, Sun F, Ma Y, Sun G . Association between mobilization of circulating endothelial progenitor cells and time or degree of injury from angioplasty in patients with exertional angina: A prospective study. Exp Ther Med. 2015; 10(2):809-815. PMC: 4509458. DOI: 10.3892/etm.2015.2571. View